EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease

Shiji Xu, Wenqi Shao, Qun Wu, Jing Zhu, Baishen Pan, Beili Wang iD, Wei Guo iD

Journal of Clinical Laboratory Analysis · 2023-04 · 37 (8)

DOI: 10.1002/jcla.24890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 09.05.2023. Verfasst von Shiji Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhongshan Hospital Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Graves Disease, Hyperthyroidism. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Medical Key Specialty, Specialized Fund for the Clinical Researches of Zhongshan Hospital Affiliated Fudan University, the constructing project of clinical key disciplines in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate thyroid‐stimulating immunoglobulin (TSI) and thyrotropin receptor antibodies (TRAb) diagnostic performance for Graves' disease (GD) and determine clinical cut‐off value for diagnosing GD.

Methods

Of 1369 retrospectively enrolled subjects, 1364 had a definitive diagnosis of untreated GD (GD‐UT, n = 87); treated GD (GD‐T, n = 206); autoimmune thyroid disease (AIT, n = 241); thyroid nodules (TN, n = 677); subacute thyroiditis (ST, n = 28); healthy subjects (HS, n = 125); other diseases with serological hyperthyroidism ( n = 5) and were grouped into the following: UT‐GD and control groups (AIT, TN, ST, and HS); and UT‐GD and non‐GD hyperthyroidism groups. Diagnostic performance of TSI and TRAb was evaluated using area under the curve (AUC) of receiver‐operating characteristic (ROC) curve, and optimal clinical cut‐off value was determined using maximization of Youden index.

Results

TRAb AUC and clinical cut‐off value for diagnosing GD were 0.981 and 1.245 IU/L (sensitivity, 96.6%; specificity, 97.1%; positive predictive value [PPV], 71.8%; negative predictive value [NPV], 99.9%; positive likelihood ratio [PLR], 33.31; negative likelihood ratio [NLR, 0.035), respectively, for the GD‐UT and control groups. Those for TSI were 0.992 and 0.467 IU/L (sensitivity 98.8%; specificity, 96.4%; PPV, 68.8%; NPV, 99.9%; PLR, 27.472; NLR, 0.011). Those for TRAb in GD‐UT and non‐GD hyperthyroidism groups were 0.923 and 1.78 IU/L (sensitivity, 92.0%; specificity, 89.1%; PPV, 93%; NPV, 87.5%; PLR, 8.44; NLR, 0.089), respectively. For TSI, these were 0.92 and 0.545 IU/L (sensitivity, 97.7%; specificity, 83.6%; PPV, 90.4%; NPV, 95.8%; PLR27.472, NLR, 0.011), respectively.

Conclusion

TSI diagnostic performance for GD was excellent and had better sensitivity than TRAb.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseHyperthyroidismHumansImmunoglobulins, Thyroid-StimulatingLong-Acting Thyroid StimulatorReceptors, ThyrotropinRetrospective StudiesThyrotropin

Stichwörter der Autor:innen

Graves' diseasediagnostic performancethyroid-stimulating immunoglobulinthyrotropin receptor antibody

Substanzen

Immunoglobulins, Thyroid-StimulatingLong-Acting Thyroid StimulatorReceptors, ThyrotropinThyrotropin

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Zhongshan Hospital Fudan University, Shanghai, China.

ORCID-Profile: Beili Wang, Wei Guo

Förderung

  • Shanghai Medical Key Specialty
  • Specialized Fund for the Clinical Researches of Zhongshan Hospital Affiliated Fudan University
  • the constructing project of clinical key disciplines in Shanghai
  • The National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Xu, S., Shao, W., Wu, Q., Zhu, J., Pan, B., Wang, B., & Guo, W. (2023). Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease. Journal of Clinical Laboratory Analysis, 37(8). https://doi.org/10.1002/jcla.24890

Vancouver

Xu S, Shao W, Wu Q, Zhu J, Pan B, Wang B, et al. Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease. Journal of Clinical Laboratory Analysis. 2023;37(8). doi:10.1002/jcla.24890

BibTeX
@article{Xu2023,
  author = {Xu, Shiji and Shao, Wenqi and Wu, Qun and Zhu, Jing and Pan, Baishen and Wang, Beili and Guo, Wei},
  title = {Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2023},
  volume = {37},
  number = {8},
  doi = {10.1002/jcla.24890}
}
Kostenlos starten →